Rockefeller University Press, Journal of Experimental Medicine, 11(217), 2020
DOI: 10.1084/jem.20200684
Full text: Unavailable
In this issue of JEM, Du et al. (https://doi.org/10.1084/jem.20191115) report that enhancement of the β-catenin signaling by Wnt or EGF treatment increases the expression of PD-L1 in an AKT and β-catenin–dependent manner, and blocking the AKT pathway synergizes with anti–PD-1 in a glioblastoma model.